Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms

Tumor marker determinations are valuable tools for the guidance of breast cancer patients during the course of disease. They are assessed on diverse analytical platforms that may be associated with differences according to the methods applied and the clinical performance. To investigate the method d...

Descripción completa

Detalles Bibliográficos
Autores principales: Schröder, Lars, Mallmann, Michael R., Domroese, Christian M., Wefers, Natalie, Dolscheid-Pommerich, Ramona, Stoffel-Wagner, Birgit, Trulson, Inga, Vahldiek, Kai, Klawonn, Frank, Holdenrieder, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572608/
https://www.ncbi.nlm.nih.gov/pubmed/37835844
http://dx.doi.org/10.3390/diagnostics13193101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572608/
https://www.ncbi.nlm.nih.gov/pubmed/37835844
http://dx.doi.org/10.3390/diagnostics13193101

Ejemplares similares